The Peptide Directory

Peptide Therapy: Immune Support

Thymosin alpha-1 (thymalfasin) is approved in a number of countries outside the US for hepatitis B; LL-37, KPV and thymic bioregulators remain research compounds without FDA approval.

Immune Support peptides by evidence

Immune Support peptides ordered by evidence level, then by PubMed-indexed clinical trials (searched October 19, 2026).
CompoundFDA statusEvidence levelPubMed papersTagged trials
ThymalinNot FDA-approved (used in Russia)Clinical trials / approved abroad23412
Thymosin alpha-1Not FDA-approved (approved in some other countries)Clinical trials / approved abroad5911
ThymogenNot FDA-approved (used in Russia)Clinical trials / approved abroad815
VIPNot approved (research only)Preclinical or minimal8,400110
LL-37Not approved (research only)Preclinical or minimal2,54360
TB-500Not approved (research only)Preclinical or minimal6023
BronchogenNot approved (research only)Preclinical or minimal70
ChonlutenNot approved (research only)Preclinical or minimal10
CrystagenNot approved (research only)Preclinical or minimal——
VilonNot approved (research only)Preclinical or minimal——

Reconstitution math

TB-500 10 mg vial mathLL-37 5 mg vial mathCrystagen 20 mg vial mathChonluten 20 mg vial math

How people access immune support treatment

No compound in this category has an FDA-approved product, so any prescription is off-label or compounded, and "research peptide" vials are not approved for human use.

In our clinic directory, 1,417 verified clinics name a related service on their own websites: Peptide therapy 1,417. 779 of them mention telehealth. Most listings are in Texas (183), Florida (157), California (118), Tennessee (66), Arizona (64).

Telehealth and clinics

We have not verified a telehealth provider that lists immune support peptides item by item.

In person: browse verified peptide clinics by state. Compare options: best immune support peptides by evidence.